Abstract
The residence time distribution of noneliminated solutes in the liver can be represented by a variety of stochastic models. The dispersion model (closed and mixed boundary conditions), gamma distribution, log normal distribution and normal distribution models were used to describe output concentration-time profiles after bolus injections into the liver of labeled erythrocytes and albumin. The dispersion model and log normal distribution model provide the best representation of the data and give similar estimates of relative dispersion and availability for varying hepatocellular enzyme activity. The availability of solutes eliminated from the liver by first-order kinetics is determined by the residence time distribution of the solute in the liver and not on events occurring in the liver when a uniform enzyme distribution is assumed. Both enzyme heterogeneity (axial or transverse) and hepatocyte permeability may affect solute availability. A more complex model accounting for enzyme distribution and the micromixing of solute within the liver is required for solutes undergoing saturable kinetics.
Similar content being viewed by others
References
J. G. Wagner.Fundamentals of Clinical Pharmacokinetics, Drug Intelligence Publications, Hamilton, IL, 1975, pp. 57–128.
M. Rowland and T. N. Tozer.Clinical Pharmacokinetics: Concepts and Applications, Lea & Febiger, Philadelphia, 1980, pp. 48–76.
M. S. Roberts and M. Rowland. Hepatic elimination-dispersion model.J. Pharm. Sci. 74:585–587 (1985).
K. S. Pang and M. Rowland. Hepatic clearance of drugs. 1. Theoretical considerations of a “well stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and hepatocellular enzymatic activity on hepatic drug clearance.J. Pharmacokin. Biopharm. 5:625–653 (1977).
O. Levenspiel.Chemical Reaction Engineering, Wiley, New York, 1972, pp. 253–315.
L. Bass, P. J. Robinson, and A. J. Bracken. Hepatic elimination of flowing substances: The distributed mode.J. Theor. Biol. 72:161–184 (1978).
E. L. Forker and B. Luxon. Hepatic transport kinetics and plasma disappearance curves: distributed modeling versus conventional approach.Am. J. Physiol. 235:E648-E660 (1978).
M. S. Roberts and M. Rowland. A dispersion model of hepatic elimination. 2. Steady-state considerations. Influence of blood flow, protein binding and hepatocellular enzymatic activity.J. Pharmacokin. Biopharm. 14:261–288 (1986).
L. Bass. Convection-dispersion modelling of hepatic elimination.J. Pharm. Sci. 75:321–322 (1986).
L. Bass, M. S. Roberts, and P. J. Robinson. On the relation between extended forms of the sinusoidal perfusion and of the convection-dispersion models of hepatic elimination.J. Theor. Biol. 126:457–482 (1987).
M. Weiss. Moments of physiological transit time distributions and time course of drug disposition in the body.J. Math. Biol. 15:305–318 (1982).
M. S. Roberts and M. Rowland. A dispersion model of hepatic elimination. 1. Formulation of the model and bolus considerations.J. Pharmacokin. Biopharm. 14:227–260 (1986).
J. J. Gumucio and D. L. Miller. Functional implications of liver cell heterogeneity.Gastroenterology 60:393–403 (1981).
C. A. Goresky. Kinetic interpretation of hepatic multiple-indicator dilution studies.Am. J. Physiol. 245:G1-G12 (1983).
C. P. Rose and C. A. Goresky. Vasomotor control of capillary transit time heterogeneity in the canine coronary circulation.Circ. Res. 39:541–554 (1976).
M. S. Roberts and M. Rowland. A dispersion model of hepatic elimination. 3. Application to metabolite formation and elimination kinetics.J. Pharmacokin. Biopharm. 14:289–308 (1986).
M. S. Roberts and M. Rowland. Correlation between in-vitro microsomal enzyme activity and whole organ hepatic elimination kinetics; analysis with a dispersion model.J. Pharm. Pharmacol. 38:117–181 (1986).
N. L. Johnson and S. Kotz.Continuous Univariant Distributions—1, Houghton Mifflin, Boston, 1970, pp. 137–153.
M. C. K. Tweedie. Functions of a statistical variate with given means with special reference to Laplacian distributions.Proc. Cambr. Phil. Soc. 41:41–49 (1947).
C. W. Sheppard.Basic Principles of the Tracer Method, Wiley, New York, 1962, pp. 166–213.
M. E. Wise. Tracer dilution curves in cardiology and random walk and lognormal distributions.Acta Physiol. Pharmacol. Neerland. 4:175–204 (1966).
M. Weiss. Use of gamma distributed residence times in pharmacokinetics.Eur. J. Clin. Pharmacol. 25:695–702 (1983).
N. L. Johnson and S. Kotz.Continuous Univeriant Distributions—1, Houghton Mifflin, Boston, 1970, pp. 166–206.
C. Y. Wen and L. T. Fan.Models for Flow Systems and Chemical Reactors, Marcel Dekker, New York, 1985, pp. 281–330.
B. A. Buffham and L. G. Gibilaro. A generalisation of the tank-in-series mixing model.Am. Inst. Chem. Eng. J. 14:805–806 (1968).
A. W. Wolkoff, C. A. Goresky, J. Sellin, Z. Gatmaitan, and I. M. Arias. Role of ligandin in transfer of bilirubin from plasma into liver.Am. J. Physiol. 236:E636-E648 (1979).
A. B. Ahmad. Ph.D. thesis, University of Bath (1982).
F. Galton. The geometric mean in vital and social statistics.Proc. Roy. Soc. London 29:365–367 (1879).
K. V. Bury.Statistical Models in Applied Science, Wiley, New York, 1974, p. 279.
S. Keiding and E. Chiaratini. Effect of sinusoidal perfusion on galactose elimination in perfused rat liver.J. Pharmacol. Exp. Ther. 205:415–470 (1978).
S. Keiding and E. Steiness. Flow dependence of propranolol elimination in perfused rat liver.J. Pharmacol. Exp. Ther. 230:474–477 (1984).
K. L. Zierler. Theory on the use of arterio venous concentration differences for measuring metabolism in steady and non-steady states.J. Clin. Invest 40:2111–2125 (1961).
Y. Sawada, Y. Sugiyama, Y. Miyamoto, T. Iga, and M. Hanano. Hepatic drug clearance model: comparison among the distributed, parallel-tube and well-stirred models.Chem. Pharm. Bull. 33:319–326 (1985).
M. Rowland, L. Z. Benet, and G. G. Graham. Clearance concepts in pharmacokinetics.J. Pharm. Biopharm. 1:123–136 (1973).
P. V. Pederson. Curve fitting and modelling in pharmacokinetics and some practical experience with NONLIN and a new programme FUNFIT.J. Pharmacokin. Biopharm. 5:513–531 (1977).
K. S. Pang and M. Rowland. Hepatic clearance of drugs. II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liverin situ preparation.J. Pharmacokin. Biopharm. 5: 655–680 (1977).
A. B. Ahmad, P. N. Bennett, and M. Rowland. Models of hepatic drug clearance: Discrimination between the “well-stirred” and “ parallel-tube” models.J. Pharm. Pharmacol. 35:219–244 (1983).
D. B. Jones, D. J. Morgan, G. W. Mihaly, L. K. Webster, and R. A. Smallwood. Discrimination between venous equilibrium and sinusoidal models of hepatic drug elimination in isolated perfused rat liver by perturbation of propranolol protein binding.J. Pharmacol. Exp. Ther. 229:522–526 (1984).
L. Bass. Flow dependence of first-order uptake of substances by heterogeneously perfused organs.J. Theor. Biol. 86:365–376 (1980).
E. L. Forker and B. A. Luxon. Hepatic transport kinetics: effect of an anatomic and metabolic heterogeneity on estimates of the average transfer coefficients.Am. J. Physiol. 243: G532-G540 (1982).
E. L. Forker and B. A. Luxon. Albumin binding and hepatic uptake: the importance of model selection.J. Pharm. Sci. 72:1322–1323 (1983).
L. M. Riccardi.Diffusion Processes and Related Topics in Biology. Lecture Notes in Biomathematics, Vol. 14, Springer, New York, 1977, pp. 59–65.
J. F. Wehner and R. H. Wilhelm. Boundary conditions of flow reactor.Chem. Eng. Sci. 8:89–93 (1956).
R. A. Weisiger. Dissociation from albumin: A potentially rate-limiting step in the clearance of substances by the liver.Proc. Natl. Acad. Sci. (U.S.)82:1563–1567 (1985).
R. A. Weisiger, C. M. Mendel, and R. C. Cavalieri. The hepatic sinusoid is not well-stirred. Estimation of the degree of axial mixing by analysis of lobuler concentration gradients formed during uptake of thyroxine by the perfused rat liver.J. Pharm. Sci. 75: 233–237 (1986).
L. Bass. Saturation kinetics in hepatic drug removal: A statistical approach to functional heterogeneity.Am. J. Physiol. 244:G583-G589 (1983).
A. Koo, I. Y. Liang, and K. K. Cheng. The terminal hepatic microcirculation in the rat.Quart. J. Exp. Physiol. 60:261–266 (1975).
J. L. Folks and R. S. Chhikara. The inverse gaussian distribution and its statistical application—A review.J. Roy. Stat. Soc. B40:263–289 (1978).
C. A. Goresky, G. G. Bach, and B. E. Nadeau. On the uptake of materials by the intact liver: The transport and net removal of galactose.J. Clin. Invest. 52:991–1009 (1973).
K. S. Pang and R. N. Stillweil. An understanding of the role of enzyme localisation of the liver on metabolite kinetics: A computer simulation.J. Pharmacokin. Biopharm. 11:451–468 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roberts, M.S., Donaldson, J.D. & Rowland, M. Models of hepatic elimination: Comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination. Journal of Pharmacokinetics and Biopharmaceutics 16, 41–83 (1988). https://doi.org/10.1007/BF01061862
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01061862